Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing

Journal of Cellular Biochemistry

Volumn 60, Issue 3, 1996, Pages 379-386

  Moses, M A ^a,b   Marikovsky, M ^d   Harper, J W ^a,b   Vogt, P ^e   Eriksson, E ^b,c   Klagsbrun, M ^a,b   Langer, R ^a,f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e ST JOSEF HOSPITAL   (Germany)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

chronic wounds; connective tissue remodeling; metalloproteinase; metalloproteinase inhibitor; wound healing

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE B; METALLOPROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FEMALE; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; REGENERATION; SWINE; WOUND HEALING;

ANIMALS; COLLAGEN; FEMALE; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PHENANTHROLINES; PROTEASE INHIBITORS; SWINE; WOUND HEALING;

EID: 0029965936     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T     Document Type: Article

References (37)

1. Braunhut SJ, Moses MA (1994): Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TEMP). J Biol Chem 269:13472-13479.
2. Breuing K, Eriksson E, Liu P, Miller DR (1992): Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res 52:50-58.
3. Buckley-Sturrock A, Woodward SC, Senior RM, Griffin GL, Klagsbrun M, Davidson JM (1989): Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 138:70-78.
4. Chen WY, John A, Rogers A, Lydon MJ (1992): Characterization of biologic properties of wound fluid collected during early stages of wound healing. J Invest Dermatol 99:559-564.
5. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger JL, He C, Bauer EA, Goldberg GI (1988): H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587.
6. Docherty AJP, Murphy G ( 1990): The tissue metalloproteinase family and the inhibitor TEMP: A study using cDNAs and recombinant proteins. Ann Rheum Dis 49:469-479.
7. Grinnell F, Ho CH, Wysocki A (1992): Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting and cell adhesion assays. J Invest Dermatol 98:410-416.
8. Hasebe T, Harasawa S, Miwa T, Shibata T, Inayama S (1987): Collagen and collagenase in ulcer tissue. 1. The healing process of acetic acid ulcers in rats. Tokai J Exp Clin Med 12:147-158.
9. He C, Wilhelm SM, Pentland AP, Manner BL, Grant GA, Eisen AZ, Goldberg GI (1989): Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632-2636.
10. Hennessey PJ, Black CT, Andrassy RJ (1990): Epidermal growth factor and insulin act synergistically during diabetic healing. Arch Surg 125:926-929.
11. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z (1986): Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261:2814-2818.
12. Howard EW, Bullen EC, Banda MJ (1991): Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases 2. J Biol Chem 266:13064-13069.
13. Johnson-Wint B (1980): A quantitative collagen film collagenase assay for large numbers of samples. Anal Biochem 104:175-181.
14. Laemmli UK (1970): Cleavage of structural protein during the assembly of the head of bacteriophage-T4. Nature 227:680-685.
15. Lefebvre V, Peeters-Joris C, Vaes G (1991): Production of gelatin-degrading matrix metalloproteinases ("type IV collagenases") and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. Biochim Biophys Acta 1094:8-18.
16. Mallya SK, Van Wart HE (1989): Mechanism of inhibition of human neutrophil collagenase by GoId(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site. J Biol Chem 264:1594-1601.
17. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M (1993): Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci 90:3889-3893.
18. Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 6:121-125.
19. Moses MA, Sudhalter J, Langer R (1990): Identification of an inhibitor of neovascularization from cartilage. Science 248:1408-1410.
20. Murray JB, Allison K, Sudhalter J, Langer R (1986): Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor. J Biol Chem 261:4154-4159.
21. Nagase H, Enghild JJ, Suzuki K, Salveson G (1990): Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 19:5783-5789.
22. Porras-Reyes BH, Blair HC, Jeffrey JJ, Mustoe TA (1991): Collagenase production at the border of granulation tissue in a healing wound: Macrophage and mesenchymal collagenase production in vivo. Connect Tissue Res 27:63-71.
23. Ross R (1968): The fibroblast and wound repair. Biol Rev 43:51-96.
24. Saarialho-Kere UK, Chang ES, Welgus HG, Parks WC (1992): Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 90:1952-1957.
25. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H (1994): Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70:176-182.
26. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994): A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
27. Shapiro SD, Kobayashi DK, Welgus HG (1992): Identification of TIMP-2 in human alveolar macrophages. J Biol Chem 267:13890-13894.
28. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE (1990): Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine-switch" mechanism for activation. Proc Natl Acad Sci USA 87:364-368.
29. Stetler-Stevenson WG, Krutzsch HG, Wacher MP, Margulies IMK, Liotta LA (1989): Tissue inhibitor of metalloproteinase (TIMP-2) J Biol Chem 264:1353-1356.
30. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA (1990): Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938.
31. Towbin H, Staehelin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc Natl Acad Sci USA 76:4350-4354.
32. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI (1990): Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin Invest 86:1496-1502.
33. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky C (1989): Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109:877-889.
34. Whalen GF, Zetter BR (1992): Angiogenesis. In Cohen IK, Diegelmann RF, Linblad WJ (eds): "Wound Healing: Biochemical and Clinical Aspects." Philadelphia: W.B. Saunders Company, pp 77-95.
35. Woessner JF (1991): Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5-2145-2154.
36. Wysocki AB, Staiano-Coico L, Grinnell F (1991): Proteolytic enzyme cascade is over-expressed in chronic wounds. J Cell Biol 115:137a.
37. Wysocki AB, Staiano-Coieo L, Grinnell F (1993): Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68.